- Filed
- Feb 24, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · Feb 23, 2026 | 405.12M sh |
| Shares Diluted | FY 2025 · Dec 31, 2025 | 381.6M sh |
| Shares Diluted | FY 2025 · Dec 31, 2024 | 323.1M sh |
| Shares Diluted | FY 2025 · Dec 31, 2023 | 252.44M sh |
| Stock Repurchased | FY 2025 · Dec 31, 2025 | $89.59M |
| Stock Repurchased | FY 2025 · Dec 31, 2024 | $27.64M |
| Stock Repurchased | FY 2025 · Dec 31, 2023 | $3.9M |
| Capex | FY 2025 · Dec 31, 2025 | $487.92M |
| Capex | FY 2025 · Dec 31, 2024 | $139.5M |
| Capex | FY 2025 · Dec 31, 2023 | $20.48M |
| Operating Cash Flow | FY 2025 · Dec 31, 2025 | −$207.94M |
| Operating Cash Flow | FY 2025 · Dec 31, 2024 | −$87.51M |
| Operating Cash Flow | FY 2025 · Dec 31, 2023 | −$94.24M |
| Long Term Debt | FY 2025 · Dec 31, 2025 | $2.71B |
| Long Term Debt | FY 2025 · Dec 31, 2024 | $0 |
| Short Term Debt | FY 2025 · Dec 31, 2025 | $37.79M |
| Short Term Debt | FY 2025 · Dec 31, 2024 | $32.33M |
| Cash And Equivalents | FY 2025 · Dec 31, 2025 | $628.26M |
| Cash And Equivalents | FY 2025 · Dec 31, 2024 | $5.59M |
| Cash And Equivalents restated | FY 2025 · Dec 31, 2023 | $74.18M |
| Stockholders Equity | FY 2025 · Dec 31, 2025 | $805.54M |
| Stockholders Equity | FY 2025 · Dec 31, 2024 | $681.95M |
| Stockholders Equity | FY 2025 · Dec 31, 2023 | $491.34M |
| Stockholders Equity | FY 2025 · Dec 31, 2022 | $342.89M |
| Current Liabilities | FY 2025 · Dec 31, 2025 | $699.07M |
| Current Liabilities | FY 2025 · Dec 31, 2024 | $131.78M |
| Total Liabilities | FY 2025 · Dec 31, 2025 | $3.46B |
| Total Liabilities | FY 2025 · Dec 31, 2024 | $173.49M |
| Current Assets | FY 2025 · Dec 31, 2025 | $2.65B |
| Current Assets | FY 2025 · Dec 31, 2024 | $168.21M |
| Total Assets | FY 2025 · Dec 31, 2025 | $4.29B |
| Total Assets | FY 2025 · Dec 31, 2024 | $855.45M |
| Eps Diluted | FY 2025 · Dec 31, 2025 | −$2.15 |
| Eps Diluted | FY 2025 · Dec 31, 2024 | −$0.14 |
| Eps Diluted | FY 2025 · Dec 31, 2023 | −$0.10 |
| Eps Basic | FY 2025 · Dec 31, 2025 | −$2.15 |
| Eps Basic | FY 2025 · Dec 31, 2024 | −$0.14 |
| Eps Basic | FY 2025 · Dec 31, 2023 | −$0.10 |
| Sga Expense | FY 2025 · Dec 31, 2025 | $36.38M |
| Sga Expense | FY 2025 · Dec 31, 2024 | $32.66M |
| Sga Expense restated | FY 2025 · Dec 31, 2023 | $27.8M |
| Net Income | FY 2025 · Dec 31, 2025 | −$822.24M |
| Net Income | FY 2025 · Dec 31, 2024 | −$44.64M |
| Net Income | FY 2025 · Dec 31, 2023 | −$25.78M |
| Operating Income | FY 2025 · Dec 31, 2025 | −$421.56M |
| Operating Income | FY 2025 · Dec 31, 2024 | −$43.7M |
| Operating Income | FY 2025 · Dec 31, 2023 | −$20.12M |
| Cost Of Revenue | FY 2025 · Dec 31, 2025 | $81.22M |
| Cost Of Revenue | FY 2025 · Dec 31, 2024 | $62.36M |
| Cost Of Revenue | FY 2025 · Dec 31, 2023 | $50.31M |
| Revenue | FY 2025 · Dec 31, 2025 | $223.94M |
| Revenue | FY 2025 · Dec 31, 2024 | $151.27M |
| Revenue | FY 2025 · Dec 31, 2023 | $126.84M |